Orthopedic firms fight for stability during the pandemic.
The orthopedics market has been on a wild ride since the beginning of the pandemic. Shutdowns and uncertainty with elective procedures, which include but are not limited to orthopedics, have put a lot of twists and turns in the market. Companies in the space have seen hits to revenue and have had to modify plans to make it through this fluid market.
Rewind the clock to April of 2020. American Academy of Orthopedic Surgeons (AAOS) issued guidance that would set the tone for orthopedic procedures until this day. The organization gave guidance that suggested every locality should make its own decisions based on the availability of resources and personnel.
A growth-driven and strategic executive, Peter Coffaro commands more than 20 years of progressive management success within the orthopedic industry. Recognized by MedReps.com and the World Journal of Orthopedics as one of the top medical sales influencers in the industry; he has 10 years of combined sales management experience and has held positions as a Director, General Manager and Distributor. Peter has worked for some of the top orthopedic companies in the world - Zimmer, DePuy and Stryker. He is also the founder of OrthoFeed: a popular blog that covers orthopedic news and emerging medical technologies. Peter is a three-time Hall of Fame award winner at Johnson and Johnson and has an extensive background in organizational development, business development, sales management, digital marketing and professional education. Peter holds a B.S. degree in Biology from Northern Illinois University.
Smith & Nephew, the global medical technology business, today presented new data at the International Society for Pharmacoeconomics and Outcomes Research (ISPOR), Annual Meeting in New Orleans. […]
(ODT) – Those who have been in this industry for more than a few years realize implant technology has not changed all that much. Sure, there are new product releases offering innovative benefits not previously available. […]
(MEDTECHDIVE) – Moody’s sees the U.S. medical device industry as a bright spot in healthcare in the year ahead. In contrast to the positive outlook for devices, the credit ratings agency gave a stable outlook to the global pharmaceuticals and U.S. for-profit hospital industries. […]
Be the first to comment